Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB-NOLI vs RUBIDIUM RB-82: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROZANOLIXIZUMAB-NOLI vs RUBIDIUM RB-82: Safety Overview

Metric ROZANOLIXIZUMAB-NOLI RUBIDIUM RB-82
Total FAERS Reports 349 138
Deaths Reported 4 0
Death Rate 1.1% N/A
Hospitalizations 84 2
Average Patient Age 55.1 yrs 66.9 yrs
% Female Patients 63.3% 50.4%
FDA Approval Date N/A Dec 29, 1989
Manufacturer N/A Jubilant DraxImage Inc., dba Jubilant...
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription